Exagen Inc. (XGN)

NASDAQ: XGN · USD

$8.33

+0.55 (+7.1%)· Recorded snapshot

Market cap	201.8M
Revenue (ttm)	71.1M
Net income (ttm)	-18.9M
EPS (ttm)	-$0.80
Shares out	24.2M
Volume	327,872
Beta	2.12

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 71.1M
Net income (ttm): -18.9M
EPS (ttm): -$0.80
Market cap: 201.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-113.8

P25 n/aP50 n/aP75 n/a

ROIC-19.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All XGN indicators

Market & fundamental data

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001274737
Company name	Exagen Inc.
Country	United States
Country code	US
CUSIP number	30068X103
Earnings date	2026-11-10
Earnings time	bmo
Employees	220
Employees change	5
Employees growth	2.33%
Enterprise value	$204.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2002
Industry	Diagnostics & Research
IPO date	2019-09-19
Is primary listing	Yes
Is SPAC	No
ISIN number	US30068X1037
Last 10-K release date	2026-03-10
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$201.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$8.33
Price currency	USD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-28
Symbol	XGN
U.S. state	California
Website	https://www.exagen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-9.61%
EV/Sales	2.69x
FCF / EV yield	-3.96%
FCF yield	-4.03%
Forward EV/Sales	2.5x
Forward P/S	2.46x
Industry forward P/E	30.92x
Industry P/E	50.57x
P/B ratio	15.41x
P/S ratio	2.65x
Price / tangible book value	15.43x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-18.58%
EBITDA margin	-15.15%
Gross margin	58.64%
Operating margin	-18.58%
Pretax margin	-26.54%
Profit margin	-26.61%
Profit per employee	$-86,014
Revenue per employee	$323,282
ROA	-14.92%
ROA (5Y)	-18.54%
ROCE	-34.33%
ROE	-113.82%
ROE (5Y)	-86.22%
ROIC	-19.16%
SBC / revenue	4.12%
Tax / revenue	0.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	19.23%
Gross profit growth (Q)	17.53%
Gross profit growth 3Y	13.07%
Gross profit growth 5Y	8.32%
Net income growth quarters	1
Net income growth years	0
Revenue growth	20.83%
Revenue growth (Q)	15.92%
Revenue growth (QoQ)	15.23%
Revenue growth 10Y	36.99%
Revenue growth 3Y	10.35%
Revenue growth 5Y	8.73%
Revenue growth quarters	6
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.1M
Depreciation and amortization	$2.4M
EBIT	$-13.2M
EBITDA	$-10.8M
EPS	$-0.80
FCF per share	$-0.31
Financing cash flow	$2.1M
Free cash flow	$-7.6M
Free cash flow minus SBC	$-10.5M
Gross profit	$41.7M
Income taxes	$50,000
Investing cash flow	$-1.1M
Net borrowing	$-1.4M
Net cash flow	$-5.4M
Net income	$-18.9M
Operating cash flow minus SBC	$-9.4M
Operating income	$-13.2M
Revenue	$71.1M
Stock-based compensation	$2.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-5.26
Book value per share	$0.50
Debt / equity	2.26
Interest coverage	-2.58
Long-term assets	$9.1M
Long-term liabilities	$26.3M
Net cash (debt)	$-3.1M
Net cash / market cap	-1.63%
Net debt / equity	0.25
Piotroski F-Score	2
Property, plant and equipment	$8.5M
Shareholders' equity	$12.2M
Tangible book value	$12.2M
Tangible book value per share	$0.50
Total assets	$51.9M
Total cash	$24.6M
Total debt	$27.7M
Total liabilities	$39.7M
WACC	15.75%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.29
Current assets	$42.9M
Current liabilities	$13.5M
Current ratio	3.18
Inventory turnover	7.45
Net working capital	$7.4M
Quick ratio	2.75
Working capital	$29.4M
Working capital turnover	2.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-23.9%
Dividend yield	0%
Shareholder yield	-23.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$5.44
1D price change	7.07%
1M price change	-3.33%
1M total return	-3.33%
1W price change	13.77%
1W total return	13.77%
1Y price change	-29.22%
1Y return CAGR	-29.24%
1Y total return	-29.22%
20-day SMA	$8.01
200-day SMA	$4.99
3M price change	91.59%
3M total return	91.59%
3Y price change	458.28%
3Y return CAGR	77.38%
3Y total return	458.28%
50-day SMA	$7.88
50-day SMA vs 200-day SMA	50over200
52-week high	$11.98
52-week high date	2025-10-28
52-week low	$2.59
52-week low date	2026-03-30
5Y price change	-28.56%
5Y return CAGR	-6.51%
5Y total return	-28.56%
6M price change	207.66%
6M total return	207.66%
All-time high	$29.86
All-time high date	2019-12-26
All-time low	$1.30
All-time low date	2024-04-16
Average true range (ATR)	$0.53
Average volume	363.9K
Beta (1Y)	3.19
Beta (2Y)	1.75
Beta (5Y)	2.12
Change from 52-week high	-30.47%
Change from 52-week low	221.62%
Change from all-time high	-71.77%
Change from all-time low	548.46%
Change from open	-0.24%
Day's gap	7.33%
Dollar volume	$2.7M
High price	$8.50
Low price	$8.33
Monthly RSI	60.49
Open price	$8.35
Position in 52-week range	0%
Premarket change	0%
Premarket close	$7.78
Premarket price	$7.78
Previous close	$7.78
Price vs 150-day SMA	54.96%
Price vs 20-day SMA	5.26%
Price vs 200-day SMA	68.9%
Price vs 50-day SMA	6.98%
Relative volume	0.9
Return from IPO open	-53.69%
Return from IPO price	-44.43%
RSI	57.43
Sharpe ratio	-0.07
Sharpe ratio (3Y)	1
Sharpe ratio (5Y)	0.26
Sortino ratio	-0.04
Sortino ratio (3Y)	1.88
Sortino ratio (5Y)	0.52
Volume	327.9K
Weekly RSI	62.32
YTD price change	38.65%
YTD total return	38.65%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13.5M
Float percentage	55.59%
Shares change (QoQ)	1.3%
Shares change (YoY)	23.9%
Shares held by insiders	19.22%
Shares held by institutions	32.93%
Shares outstanding	24.2M
Short % of float	5.23%
Short % of shares	2.91%
Short ratio	2.7 days

Deeper analysis on XGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XGN report

Is a complete XGN research report available?

No complete published report is available for Exagen Inc. (XGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Exagen Inc. (XGN)

Price

Financial snapshot

Fair-value bridge

Latest news · XGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on XGN

Frequently asked questions